Mon Oct 06 20:00:27 UTC 2025: ## Summary:
Following child deaths linked to cough and cold syrups in Madhya Pradesh and Rajasthan, the Karnataka Health Department has issued an advisory to healthcare institutions to refrain from prescribing or dispensing these syrups to children under two years old.
## News Article:
**Karnataka Bans Cough Syrups for Infants After Fatalities in Neighboring States**
BANGALORE, India – The Karnataka Health Department has taken a proactive step to safeguard infant health by issuing an advisory on Monday, urging healthcare institutions across the state to immediately cease the prescription and dispensing of cough and cold syrups for children under the age of two.
This urgent directive comes in the wake of reported child deaths in Madhya Pradesh and Rajasthan, raising serious concerns about the potential risks associated with these commonly used medications in young children. While the specific causes of death are still under investigation in those states, authorities are acting out of an abundance of caution to prevent similar tragedies in Karnataka.
“The safety and well-being of our children are of paramount importance,” a spokesperson for the Karnataka Health Department stated. “This advisory is a precautionary measure to mitigate any potential risk associated with the use of cough and cold syrups in infants. We urge all healthcare professionals to adhere to this directive and explore alternative treatment options for young patients suffering from coughs and colds.”
The advisory does not specify any particular brand of syrup, but rather covers all cough and cold medications marketed for or commonly used in treating infants. The department emphasizes the need for healthcare providers to carefully evaluate the risks and benefits of any medication before prescribing it to children, especially those under two years old. Parents are also encouraged to consult with their doctors about alternative remedies and treatments for their infants’ coughs and colds.
The move reflects a growing awareness of the potential dangers of over-the-counter medications in young children and underscores the importance of responsible prescribing practices. Further details regarding the advisory and recommended alternative treatments are expected to be released by the Health Department in the coming days.